Validation and genomic interrogation of the MET variant rs11762213 as a predictor of adverse outcomes in clear cell renal cell carcinoma.
A. Ari Hakimi
No relevant relationships to disclose
Irina Ostrovnaya
No relevant relationships to disclose
Anders Jacobsen
No relevant relationships to disclose
Jonathan A. Coleman
No relevant relationships to disclose
Paul Russo
No relevant relationships to disclose
Roy Mano
No relevant relationships to disclose
Alexander Sankin
No relevant relationships to disclose
Robert John Motzer
No relevant relationships to disclose
Mark Purdue
No relevant relationships to disclose
Mark Pomerantz
No relevant relationships to disclose
Matthew L Freedman
No relevant relationships to disclose
Toni K. Choueiri
No relevant relationships to disclose
James Hsieh
No relevant relationships to disclose
Robert J. Klein
No relevant relationships to disclose